William Romov is an analyst for Investing Daily. William holds a B.B.A. in Finance from James Madison University.
The mega-bank's stock has benefited substantially from measures to improve accountability.
This little biotech packed a big wallop on Monday as its stock nearly doubled. Here's why.
With a 100-plus-year history, generous dividend, and diversified portfolio, could this Big Pharma player be resistant to Trump's drug price twitterstorm?
Chesapeake still has plenty of problems but it has laid foundations for long-term growth.
Drink up some of these stocks.
It's been a week since Snap made its IPO. But investors are finally starting to get bored with this faddish stock. Here's why.
Despite an earlier announcement that the company will cap autonomous vehicle tech spending at $250 million, Intel has made a giant investment in this Israeli firm.
Here are three homebuilders ready to hand you profits as Trump rolls back Obama legislation.
A new market report indicates consumers now have more trust in the beleaguered burrito chain. But is it time to start piling back into its stock?
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.